What they were paid
GeneDx Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $59,639 | $230,402 | $0 | $0 | $290,041 |
| FY2024 | $52,500 | $338,480 | $0 | $0 | $390,980 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GeneDx Holdings Corp. DEF 14A filed April 30, 2026, accession 0001818331-26-000030, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance
The rest of the GeneDx board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Emily Leproust | Independent Director | $305,041 |
| Jason Ryan | Chair of the Board | $324,679 |
| Joshua Ruch | Independent Director | $297,541 |
| Katherine Stueland | Director | $0 |
| Keith Meister | Independent Director | $297,541 |
| Richard C. Pfenniger, Jr | Independent Director | $287,541 |
| Thomas Fuchs | Independent Director | $454,191 |
The full GeneDx compensation record
free company briefThis page is one director within GeneDx's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat